{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T07:43:25Z","timestamp":1771573405696,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2019YFS0324"],"award-info":[{"award-number":["2019YFS0324"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2017SZ0005"],"award-info":[{"award-number":["2017SZ0005"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["ZYGD18012"],"award-info":[{"award-number":["ZYGD18012"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computer Methods and Programs in Biomedicine"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.cmpb.2020.105458","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T17:02:50Z","timestamp":1584637370000},"page":"105458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Prediction model of the response to neoadjuvant chemotherapy in breast cancers by a Naive Bayes algorithm"],"prefix":"10.1016","volume":"192","author":[{"given":"Libo","family":"Yang","sequence":"first","affiliation":[]},{"given":"Bo","family":"Fu","sequence":"additional","affiliation":[]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[]},{"given":"Yueping","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Wenting","family":"Huang","sequence":"additional","affiliation":[]},{"given":"Sha","family":"Feng","sequence":"additional","affiliation":[]},{"given":"Lin","family":"Xiao","sequence":"additional","affiliation":[]},{"given":"Linyong","family":"Sun","sequence":"additional","affiliation":[]},{"given":"Ling","family":"Deng","sequence":"additional","affiliation":[]},{"given":"Xinyi","family":"Zheng","sequence":"additional","affiliation":[]},{"given":"Feng","family":"Ye","sequence":"additional","affiliation":[]},{"given":"Hong","family":"Bu","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.cmpb.2020.105458_bib0001","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cmpb.2020.105458_bib0002","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cmpb.2020.105458_bib0003","doi-asserted-by":"crossref","first-page":"78168","DOI":"10.18632\/oncotarget.11375","article-title":"Diagnosis and treatment pattern among rural and urban breast cancer patients in Southwest China from 2005 to 2009","volume":"7","author":"Peng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cmpb.2020.105458_bib0004","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1200\/JCO.2007.15.0235","article-title":"Preoperative chemotherapy: updates of national surgical adjuvant breast and bowel project protocols B-18 and B-27","volume":"26","author":"Rastogi","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmpb.2020.105458_bib0005","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1200\/JCO.2004.02.122","article-title":"Randomized parallel study of doxorubicin plus paclitaxel and doxorubicin plus cyclophosphamide as neoadjuvant treatment of patients with breast cancer","volume":"22","author":"Dieras","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmpb.2020.105458_bib0006","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1200\/JCO.2002.20.6.1456","article-title":"Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel","volume":"20","author":"Smith","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmpb.2020.105458_bib0007","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/cncr.23544","article-title":"Taxanes as primary chemotherapy for early breast cancer: meta-analysis of randomized trials","volume":"113","author":"Cuppone","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.cmpb.2020.105458_bib0008","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1200\/JCO.2009.23.7370","article-title":"Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer","volume":"28","author":"Denkert","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmpb.2020.105458_bib0009","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/bjs.5894","article-title":"Neoadjuvant chemotherapy for operable breast cancer","volume":"94","author":"Mieog","year":"2007","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.cmpb.2020.105458_bib0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10549-010-1103-9","article-title":"Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the Gepartrio study","volume":"124","author":"Huober","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.cmpb.2020.105458_bib0011","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00029330-200803010-00001","article-title":"Biological markers as predictive factors of response to neoadjuvant taxanes and anthracycline chemotherapy in breast carcinoma","volume":"121","author":"Zhou","year":"2008","journal-title":"Chin. Med. J. Engl."},{"key":"10.1016\/j.cmpb.2020.105458_bib0012","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/1471-2407-11-486","article-title":"Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment","volume":"11","author":"Fasching","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cmpb.2020.105458_bib0013","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13000-017-0608-5","article-title":"Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy","volume":"12","author":"Acs","year":"2017","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.cmpb.2020.105458_bib0014","doi-asserted-by":"crossref","first-page":"R126","DOI":"10.1186\/bcr3072","article-title":"Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer","volume":"13","author":"West","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.cmpb.2020.105458_bib0015","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1200\/JCO.2006.05.6861","article-title":"Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer","volume":"24","author":"Hess","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmpb.2020.105458_bib0016","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1200\/JCO.2008.18.5934","article-title":"Genomic grade index is associated with response to chemotherapy in patients with breast cancer","volume":"27","author":"Liedtke","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmpb.2020.105458_bib0017","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"Parker","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmpb.2020.105458_bib0018","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/annonc\/mdt427","article-title":"Construction of novel immune-related signature for prediction of pathological complete response to neoadjuvant chemotherapy in human breast cancer","volume":"25","author":"Sota","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cmpb.2020.105458_bib0019","series-title":"AJCC Cancer Staging Manual","author":"Edge","year":"2010"},{"key":"10.1016\/j.cmpb.2020.105458_bib0020","first-page":"13","article-title":"Harmonization of the evaluation of tumor infiltrating lymphocytes (TILs) in breast cancer: recommendations by an international TILs-working group 2014","volume":"26","author":"Roberto Salgado","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cmpb.2020.105458_bib0021","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1200\/JCO.2010.31.2835","article-title":"Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the genomic health recurrence score in early breast cancer","volume":"29","author":"Cuzick","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmpb.2020.105458_bib0022","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10549-017-4266-9","article-title":"Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancer","volume":"164","author":"Sheri","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"issue":"Suppl 1","key":"10.1016\/j.cmpb.2020.105458_bib0023","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1007\/s12032-010-9693-y","article-title":"Ki-67, topoisomerase IIalpha, and nm23-H1 proteins expression as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer","volume":"28","author":"Li","year":"2011","journal-title":"Med. Oncol."},{"key":"10.1016\/j.cmpb.2020.105458_bib0024","first-page":"4615","article-title":"Predictive biological markers for response of invasive breast cancer to anthracycline\/cyclophosphamide-based primary (radio-)chemotherapy","volume":"25","author":"Prisack","year":"2005","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cmpb.2020.105458_bib0025","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s10549-011-1687-8","article-title":"Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agents","volume":"132","author":"Kadra","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.cmpb.2020.105458_bib0026","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2010.12.014","article-title":"Estrogen receptor-related genes as an important panel of predictors for breast cancer response to neoadjuvant chemotherapy","volume":"302","author":"Chen","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cmpb.2020.105458_bib0027","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1200\/JCO.2013.55.0491","article-title":"Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199","volume":"32","author":"Adams","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmpb.2020.105458_bib0028","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/annonc\/mdu112","article-title":"Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the Finher trial","volume":"25","author":"Loi","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cmpb.2020.105458_bib0029","doi-asserted-by":"crossref","first-page":"e79775","DOI":"10.1371\/journal.pone.0079775","article-title":"Prospective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer\u2013a substudy of the neoadjuvant geparquinto trial","volume":"8","author":"Issa-Nummer","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cmpb.2020.105458_bib0030","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.18632\/oncotarget.6231","article-title":"Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials","volume":"7","author":"Kotoula","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cmpb.2020.105458_bib0031","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.humpath.2011.12.013","article-title":"Tumor-infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancer","volume":"43","author":"Yamaguchi","year":"2012","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.cmpb.2020.105458_bib0032","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1179\/joc.2007.19.6.716","article-title":"Changes in cellular immunity during chemotherapy for primary breast cancer with anthracycline regimens","volume":"19","author":"Wijayahadi","year":"2007","journal-title":"J. Chemother."},{"key":"10.1016\/j.cmpb.2020.105458_bib0033","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13058-015-0669-x","article-title":"Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer","volume":"18","author":"Verma","year":"2016","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.cmpb.2020.105458_bib0034","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10549-012-2245-8","article-title":"Intratumoral regulatory T cells as an independent predictive factor for pathological complete response to neoadjuvant paclitaxel followed by 5-FU\/epirubicin\/cyclophosphamide in breast cancer patients","volume":"136","author":"Oda","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.cmpb.2020.105458_bib0035","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1038\/bjc.2013.634","article-title":"Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer","volume":"109","author":"Seo","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cmpb.2020.105458_bib0036","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cellimm.2013.06.001","article-title":"Correlation between Th17 cells and tumor microenvironment","volume":"285","author":"Qi","year":"2013","journal-title":"Cell Immunol."},{"key":"10.1016\/j.cmpb.2020.105458_bib0037","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1158\/1078-0432.CCR-11-2210","article-title":"A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin kappa C as a compatible prognostic marker in human solid tumors","volume":"18","author":"Schmidt","year":"2012","journal-title":"Clin. Cancer Res."}],"container-title":["Computer Methods and Programs in Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260719321649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260719321649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T03:56:04Z","timestamp":1759204564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169260719321649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":37,"alternative-id":["S0169260719321649"],"URL":"https:\/\/doi.org\/10.1016\/j.cmpb.2020.105458","relation":{},"ISSN":["0169-2607"],"issn-type":[{"value":"0169-2607","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction model of the response to neoadjuvant chemotherapy in breast cancers by a Naive Bayes algorithm","name":"articletitle","label":"Article Title"},{"value":"Computer Methods and Programs in Biomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmpb.2020.105458","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105458"}}